Hemogenyx Pharmaceuticals Opens First Clinical Site for HG-CT-1 Phase I Trial Patient Recruitment Begins for CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia in Adults ...
LONDON, UK / ACCESSWIRE / December 27, 2024 / The Company announces that on 24 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs Inte ...